Kadmon Corp
MeiraGTx is a clinical-stage genetic medicine company based in New York that is dedicated to unlocking the potential of genetic therapies for both rare and prevalent diseases. The company employs pioneering technologies, including a unique riboswitch gene regulation platform, to achieve precision control of gene expression, which can transform the treatment landscape for various disorders.
With a commitment to improving patient lives, MeiraGTx integrates advanced science and an extensive manufacturing ecosystem to provide tailored treatments. Their diverse clinical pipeline reflects the company's focus on addressing inherited and non-inherited diseases through innovative approaches to genetic medicine.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.
Partial Data by Foursquare.